Intrasense (FR0011179886 – ALINS), a specialist in medical imaging software solutions and designer of Myrian®, informs its shareholders that the Combined General Meeting (ordinary and extraordinary) convened on second notice on July 12, 2022 was unable to validly deliberate, Due to lack of quorum, on draft resolutions of an extraordinary nature, the shareholders are again convened on September 1, 2022 at 2 p.m. at the registered office of the Company, located at 1231, avenue du Mondial 98 – 34000 Montpellier.
Terms of the third call
The Extraordinary General Meeting is called to deliberate on the same agenda as that appearing on the initial notice of meeting dated June 10, 2022. The resolutions adopted on second notice are not subject to a vote. Only so-called extraordinary resolutions (No. 11 to 17 and No. 19) are put to the vote.
Pursuant to an order from the President of the Commercial Court of Montpellier dated July 18, 2022, an ad hoc representative has been appointed. In particular, he will be responsible for representing defaulting minority shareholders, and will exercise their voting rights on the basis of two-thirds of positive votes and one-third of negative votes, in order to make his participation in the deliberations neutral, in terms of qualified majority. .